Nautilus Biotechnology NAUT
NASDAQ NAUT
$1.97 +0.39 (+25.08%)
As of: Oct 2, 2026 · 3:59 PM EDT

Nautilus Biotechnology (NAUT) Depreciation & Amortization (CF) (2020 - 2026)

Updated

Nautilus Biotechnology (NAUT) posted Depreciation & Amortization (CF) of $300,000 for Q2 2026, down 25.0% from $400,000 a year earlier and down 10.2% from the prior quarter.

Analysis

Nautilus Biotechnology (NAUT) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Depreciation & Amortization (CF) at Nautilus Biotechnology was $1.39 million, down 25.4% year-over-year; for FY2025, it came in at $1.7 million, down 15.0% from FY2024.

  • Annual Depreciation & Amortization (CF) shows a five-year compound annual growth rate of 19.1% (FY2020 to FY2025).
  • In prior years, Nautilus Biotechnology's Depreciation & Amortization (CF) was $2 million in FY2024 (+8.2%), $1.85 million in FY2023 (+51.9%), $1.22 million in FY2022 (+19.4%) and $1.02 million in FY2021 (+43.5%).
  • Quarterly Depreciation & Amortization (CF) has run from a low of $219,000 in Q4 2021 to a high of $549,000 in Q4 2023 over five years.
  • On a year-over-year basis, Depreciation & Amortization (CF) has declined in each of the last seven quarters, with an average decline of 17.6% over the last eight quarters.
  • The strongest year-over-year quarter for Depreciation & Amortization (CF) in the past five years was Q4 2023, with growth of 73.2%; the weakest was Q1 2026, with a decline of 33.2%.
  • According to Business Quant data, Depreciation & Amortization (CF) for the three prior quarters was $334,000 (Q1 2026), $352,000 (Q4 2025) and $400,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Thermo Fisher Scientific 249.71 Bn 228.86 Bn 4.88 Bn 331.00 Mn
2 Abbott Laboratories 171.00 Bn 142.08 Bn 7.27 Bn 402.00 Mn
3 Danaher 155.79 Bn 139.61 Bn 3.61 Bn 196.00 Mn
4 Intuitive Surgical 143.91 Bn 123.46 Bn 1.96 Bn 192.30 Mn
5 Medtronic 110.42 Bn 76.29 Bn 6.34 Bn 729.00 Mn
6 Stryker 105.71 Bn 91.82 Bn 4.50 Bn 121.00 Mn
7 Boston Scientific 63.26 Bn 58.27 Bn 3.85 Bn 355.00 Mn
8 Edwards Lifesciences 49.80 Bn 33.91 Bn 1.35 Bn 42.70 Mn
9 Becton Dickinson 48.78 Bn 45.93 Bn 2.32 Bn 564.00 Mn
10 Nautilus Biotechnology 180.66 Mn 180.66 Mn 175,000.00 300,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 300,000.00
Mar 31, 2026 334,000.00
Dec 31, 2025 352,000.00
Sep 30, 2025 400,000.00
Jun 30, 2025 400,000.00
Mar 31, 2025 500,000.00
Dec 31, 2024 457,000.00
Sep 30, 2024 500,000.00
Jun 30, 2024 500,000.00
Mar 31, 2024 516,000.00
Dec 31, 2023 549,000.00
Sep 30, 2023 500,000.00
Jun 30, 2023 400,000.00
Mar 31, 2023 400,000.00
Dec 31, 2022 317,000.00
Sep 30, 2022 300,000.00
Jun 30, 2022 300,000.00
Mar 31, 2022 300,000.00
Dec 31, 2021 219,000.00
Sep 30, 2021 300,000.00
API Access

Nautilus Biotechnology Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=NAUT&period=max&api_key=YOUR_API_KEY